Gene · 7030
Papers3,398
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,398
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| YAP1::KMT2A-Rearranged Sarcoma: Report of a New Case With Unusual Morphology and Immunohistochemical Features. | Genes Chromosomes Cancer | 2025 | 40879254 | PubTator, text mining | PubMed |
| Accuracy of Contrast-enhanced CT in Diagnosing Small-sized cT3a Renal Cell Carcinoma and Analysis of Factors Predicting Downstaging to pT1. | In Vivo | 2025 | 40877189 | PubTator, text mining | PubMed |
| TRIM63 Overexpression in FISH-Negative MiTF Family Altered Renal Cell Carcinoma (MiTF RCC). | Mod Pathol | 2025 | 40865922 | PubTator, text mining | PubMed |
| Solid pseudopapillary neoplasm of the pancreas with elevated β-HCG levels: A case report. | Medicine (Baltimore) | 2025 | 40859485 | PubTator, text mining | PubMed |
| Bilateral, multicystic fumarate hydratase-deficient renal cell carcinoma in patient with hereditary leiomyomatosis & renal cell carcinoma syndrome: A case report and review of the literature. | Diagn Pathol | 2025 | 40859301 | PubTator, text mining | PubMed |
| High content-imaging drug synergy screening identifies specific senescence-related vulnerabilities of mesenchymal neuroblastomas. | Cell Death Dis | 2025 | 40854877 | PubTator, text mining | PubMed |
| LGI3 promotes the progression of TFE3-rearranged renal cell carcinoma through GEMIN6/AURKB axis. | Oncogene | 2025 | 40849584 | PubTator, text mining | PubMed |
| Diagnosis and management of TFE3-rearranged renal cell carcinoma: case report and literature review. | BMC Urol | 2025 | 40836233 | PubTator, text mining | PubMed |
| A rare cause of diffuse alveolar hemorrhage in a pediatric patient: thigh localization of INI1-deficient epithelioid sarcoma. | Orphanet J Rare Dis | 2025 | 40830970 | PubTator, text mining | PubMed |
| Evolving trends and clinical-pathological correlations in renal cell carcinoma surgery: a decade-long study at Peking University First Hospital. | Clin Exp Med | 2025 | 40828298 | PubTator, text mining | PubMed |
| Transcriptionally up-regulation of CDKN1A/p21 by TFE3 fusion proteins worsened TFE3-rearranged renal cell carcinoma. | Sci Rep | 2025 | 40820012 | PubTator, text mining | PubMed |
| Complete Response to Nivolumab and Ipilimumab After Pazopanib Discontinuation in a Seven-Year-Old Girl With Alveolar Soft Part Sarcoma: A Case Report and Literature Review. | Cancer Rep (Hoboken) | 2025 | 40817777 | PubTator, text mining | PubMed |
| Flotillin-1 promotes the progression of hepatocellular carcinoma by activating TFE3-mediated Golgi stress response via inhibition of mTORC1/2. | World J Gastroenterol | 2025 | 40809929 | PubTator, text mining | PubMed |
| Case report: diagnostic challenges and long-term survival of a child with bronchial mucoepidermoid carcinoma. | Transl Pediatr | 2025 | 40800190 | PubTator, text mining | PubMed |
| [Clinicopathological features and survival analysis of TFE3-rearranged renal cell carcinoma with venous tumor thrombus]. | Beijing Da Xue Xue Bao Yi Xue Ban | 2025 | 40754899 | PubTator, text mining | PubMed |
| TSC2-mutated perivascular epithelioid cell tumor with partial response to mTOR inhibition: a case report and literature review. | Discov Oncol | 2025 | 40739411 | PubTator, text mining | PubMed |
| A Case of Pediatric Renal Cell Carcinoma With TFE3 Rearrangement Treated With Robot-Assisted Partial Nephrectomy. | Cureus | 2025 | 40718162 | PubTator, text mining | PubMed |
| Pigmented perivascular epithelioid cell tumors of the orbit with NONO::TFE3 fusion: Molecular evaluation and literature review. | Am J Ophthalmol Case Rep | 2025 | 40698024 | PubTator, text mining | PubMed |
| H3F3A K36M-mutant Epithelioid Neoplasm: A Report of Two Novel Cases of a Non-chondrogenic H3K36-altered Mesenchymal Tumor. | Pediatr Dev Pathol | 2025 | 40693649 | PubTator, text mining | PubMed |
| Pediatric Granular Cell Tumor of the Digital Nerve: A Case Report and Literature Review. | Eplasty | 2025 | 40661088 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7030/papers?page=11